Skip to content

Moderna MRNA Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin22.1%-33.2pp55.3%+7.1pp48.3%-4.2pp52.5%-1.6pp54.1%-0.7pp
Operating margin-153.3%+4.8pp-158.1%-3.0pp-155.2%-48.8pp-106.3%+11.0pp-117.4%+4.5pp
Net margin-143.6%+1.6pp-145.2%-5.6pp-139.6%-45.3pp-94.3%+11.4pp-105.7%+4.4pp
Returns
Return on equity-36.6%-7.7pp-28.9%+0.4pp-29.3%-1.8pp-27.5%+1.8pp-29.3%-0.6pp
Return on invested capital-42.5%-6.6pp-35.9%-2.3pp-33.6%+0.2pp-33.8%+1.4pp-35.2%+0.8pp
Efficiency
Asset turnover0.2×0.0×0.1×0.0×0.2×-0.1×0.2×0.0×0.2×0.0×
Liquidity
Current ratio2.4×-0.9×3.3×-0.6×3.9×0.0×3.9×-0.3×4.2×+0.5×
Leverage
Debt-to-equity0.2×0.0×0.2×+0.1×0.1×0.0×0.1×0.0×0.1×0.0×
Per Share
Book value per share$18.75-15.7%$22.24-7.1%$23.92-1.2%$24.22-7.1%$26.08-8.1%
Valuation
Market capitalization$20.15B+74.8%$11.52B+14.7%$10.05B-3.0%$10.36B-5.4%$10.96B-31.5%
Price / sales9.1×+3.1×5.9×+1.4×4.5×+1.1×3.4×-0.1×3.5×-1.5×
Price / book2.7×+1.4×1.3×+0.3×1.1×0.0×1.1×0.0×1.1×-0.4×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Moderna's profit margins?
Moderna (MRNA) runs a 22.1% gross margin and a -153.3% operating margin, with a -143.6% net margin.
Where do Moderna's ratios come from?
Every ratio is computed from Moderna's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.